Cargando…
Economic impact of using maternal plasma cell‐free DNA testing to guide further workup in recurrent pregnancy loss
OBJECTIVE: We have previously demonstrated that maternal‐plasma cell‐free DNA (cfDNA)‐testing can detect chromosomal anomalies in recurrent pregnancy loss (RPL) with 81.8% sensitivity and 90.3% specificity. Here we assess whether this is cost effective in guiding further workup in RPLs. METHOD: A de...
Autores principales: | Peng, Siyang, Bhatt, Sucheta, Borrell, Antoni, Yaron, Yuval |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518071/ https://www.ncbi.nlm.nih.gov/pubmed/34002411 http://dx.doi.org/10.1002/pd.5972 |
Ejemplares similares
-
Maternal plasma genome-wide cell-free DNA can detect fetal aneuploidy in early and recurrent pregnancy loss and can be used to direct further workup
por: Yaron, Yuval, et al.
Publicado: (2020) -
Diagnostic factors for recurrent pregnancy loss: an expanded workup
por: Ticconi, Carlo, et al.
Publicado: (2023) -
Recurrent pregnancy loss: diagnostic workup after two or three pregnancy losses? A systematic review of the literature and meta-analysis
por: van Dijk, Myrthe M, et al.
Publicado: (2020) -
Diagnostic workup of endocrine dysfunction in recurrent pregnancy loss: a cross-sectional study in Northeast China
por: Zhang, Liyang, et al.
Publicado: (2023) -
The presence of donor liver granuloma requiring further workup to rule out parasitic disease
por: Nawabi, Atta, et al.
Publicado: (2017)